Stephens Lowers Addus HomeCare (NASDAQ:ADUS) Price Target to $142.00

Addus HomeCare (NASDAQ:ADUS) had its target price reduced by investment analysts at Stephens from $153.00 to $142.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Stephens’ target price points to a potential upside of 46.38% from the company’s current price.

Several other analysts also recently weighed in on the stock. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. Finally, Oppenheimer boosted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare currently has an average rating of “Buy” and a consensus target price of $133.89.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $97.01 on Wednesday. Addus HomeCare has a 1 year low of $85.94 and a 1 year high of $136.72. The firm’s 50-day simple moving average is $123.94 and its 200-day simple moving average is $126.50. The firm has a market cap of $1.76 billion, a PE ratio of 22.20, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, equities analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP bought a new position in Addus HomeCare during the third quarter valued at about $28,000. Natixis boosted its holdings in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after buying an additional 148 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.